ABCL logo

AbCellera Biologics Inc. (ABCL) Selling, General & Administrative Expenses

Annual SG&A:

$85.49M+$10.31M(+13.72%)
December 31, 2024

Summary

  • As of today, ABCL annual SG&A is $85.49 million, with the most recent change of +$10.31 million (+13.72%) on December 31, 2024.
  • During the last 3 years, ABCL annual SG&A has risen by +$36.73 million (+75.32%).
  • ABCL annual SG&A is now at all-time high.

Performance

ABCL SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

Quarterly SG&A:

$24.96M+$2.97M(+13.52%)
September 30, 2025

Summary

  • As of today, ABCL quarterly SG&A is $24.96 million, with the most recent change of +$2.97 million (+13.52%) on September 30, 2025.
  • Over the past year, ABCL quarterly SG&A has increased by +$2.68 million (+12.01%).
  • ABCL quarterly SG&A is now at all-time high.

Performance

ABCL Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

TTM SG&A:

$204.28M-$171.68M(-45.66%)
September 30, 2025

Summary

  • As of today, ABCL TTM SG&A is $204.28 million, with the most recent change of -$171.68 million (-45.66%) on September 30, 2025.
  • Over the past year, ABCL TTM SG&A has increased by +$118.88 million (+139.21%).
  • ABCL TTM SG&A is now -88.31% below its all-time high of $1.75 billion.

Performance

ABCL TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

ABCL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+13.7%+12.0%+139.2%
3Y3 Years+75.3%+47.9%+210.6%
5Y5 Years+2030.9%+594.4%+2544.2%

ABCL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+75.3%at high+58.9%-88.3%at low
5Y5-Yearat high+2030.9%at high+594.4%-88.3%+2781.3%
All-TimeAll-Timeat high+2886.0%at high>+9999.0%-88.3%+2781.3%

ABCL Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$24.96M(+13.5%)
$85.18M(+3.2%)
Jun 2025
-
$21.99M(+15.3%)
$82.50M(-1.6%)
Mar 2025
-
$19.07M(-0.5%)
$83.84M(-1.9%)
Dec 2024
$85.49M(+13.7%)
$19.16M(-14.0%)
$85.49M(+0.1%)
Sep 2024
-
$22.28M(-4.5%)
$85.40M(+5.5%)
Jun 2024
-
$23.33M(+12.6%)
$80.96M(+5.2%)
Mar 2024
-
$20.72M(+8.6%)
$76.99M(+2.4%)
Dec 2023
$75.18M(+12.6%)
$19.07M(+6.9%)
$75.18M(+4.7%)
Sep 2023
-
$17.84M(-7.9%)
$71.81M(+1.3%)
Jun 2023
-
$19.36M(+2.4%)
$70.85M(+2.7%)
Mar 2023
-
$18.91M(+20.4%)
$69.02M(+3.4%)
Dec 2022
$66.75M(+36.9%)
$15.71M(-7.0%)
$66.76M(+1.5%)
Sep 2022
-
$16.88M(-3.7%)
$65.77M(+7.2%)
Jun 2022
-
$17.53M(+5.4%)
$61.38M(+8.9%)
Mar 2022
-
$16.64M(+13.1%)
$56.34M(+15.7%)
Dec 2021
$48.76M
$14.72M(+17.8%)
$48.70M(+15.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
$12.49M(-0.1%)
$42.01M(+26.9%)
Jun 2021
-
$12.50M(+38.9%)
$33.12M(+33.8%)
Mar 2021
-
$9.00M(+12.1%)
$24.75M(+57.1%)
Dec 2020
$15.75M(+292.6%)
$8.03M(+123.3%)
$15.75M(+103.9%)
Sep 2020
-
$3.59M(-13.0%)
$7.73M(+87.0%)
Jun 2020
-
$4.13M(>+9900.0%)
$4.13M(>+9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$4.01M(+40.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2018
$2.86M
-
-
Dec 2018
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00

FAQ

  • What is AbCellera Biologics Inc. annual SG&A?
  • What is the all-time high annual SG&A for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual SG&A year-on-year change?
  • What is AbCellera Biologics Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly SG&A year-on-year change?
  • What is AbCellera Biologics Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM SG&A year-on-year change?

What is AbCellera Biologics Inc. annual SG&A?

The current annual SG&A of ABCL is $85.49M

What is the all-time high annual SG&A for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual SG&A is $85.49M

What is AbCellera Biologics Inc. annual SG&A year-on-year change?

Over the past year, ABCL annual SG&A has changed by +$10.31M (+13.72%)

What is AbCellera Biologics Inc. quarterly SG&A?

The current quarterly SG&A of ABCL is $24.96M

What is the all-time high quarterly SG&A for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly SG&A is $24.96M

What is AbCellera Biologics Inc. quarterly SG&A year-on-year change?

Over the past year, ABCL quarterly SG&A has changed by +$2.68M (+12.01%)

What is AbCellera Biologics Inc. TTM SG&A?

The current TTM SG&A of ABCL is $204.28M

What is the all-time high TTM SG&A for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM SG&A is $1.75B

What is AbCellera Biologics Inc. TTM SG&A year-on-year change?

Over the past year, ABCL TTM SG&A has changed by +$118.88M (+139.21%)
On this page